Skip to content

How Peptide Signaling Works

Understanding how peptides communicate with cells and why this matters for their effects on the body.

Module 210 min read

The Lock and Key Model

Peptides work by binding to specific receptors on or inside cells — like a key fitting into a lock. When a peptide binds to its receptor, it triggers a cascade of events inside the cell that produces a biological response. This is why peptides can be so specific in their effects: they only activate cells that have the right receptor. For example, when CJC-1295 binds to the GHRH receptor on pituitary cells, it triggers those specific cells to produce and release growth hormone. Cells without GHRH receptors are not affected.

Signal Cascades

When a peptide binds to its receptor, it does not just flip a single switch. It initiates a cascade of molecular events inside the cell — like a chain of dominoes. These cascades can amplify the original signal dramatically, which is why even small amounts of a peptide can produce significant biological effects. Common signaling cascades include the cAMP/PKA pathway (used by GHRH analogs), the MAPK pathway (involved in growth and repair), and the JAK/STAT pathway (important for immune function).

Why Timing and Pulsatility Matter

Many peptide systems in the body work in pulses rather than continuous signals. Growth hormone, for example, is released in pulses throughout the day, with the largest pulse during deep sleep. This pulsatile pattern is important for maintaining receptor sensitivity. This is why some peptide therapies are designed to mimic natural pulsatile patterns (like using CJC-1295 without DAC) rather than providing a constant signal. Continuous stimulation can lead to receptor desensitization, where cells become less responsive over time.

The Importance of Receptor Selectivity

One of the key differences between peptides is how selective they are for their target receptors. Ipamorelin, for example, is highly selective for the GH secretagogue receptor, which is why it does not significantly affect cortisol or prolactin. Melanotan II, by contrast, activates multiple melanocortin receptor subtypes, leading to diverse effects (tanning, sexual function, appetite changes) and a broader side effect profile. Understanding selectivity helps explain why some peptides are considered 'cleaner' than others and why side effect profiles can vary dramatically between compounds that seem similar.

Always consult a qualified clinician

This information is for educational purposes. Peptide therapy should be guided by a licensed healthcare provider. Connect with a Noho clinician